T2 Biosystems Inc Sustainability Reports
T2 Biosystems, Inc. is an in vitro diagnostics company focused on the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. The company leverages its proprietary T2 Magnetic Resonance technology to enable fast detection directly from unpurified patient samples.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 54930027RQTU9CHLKL88
FIGI: BBG001V0G610
5 reports from 2016 to 2022